Evidence map›Paper›PMID 42635217›Full record

ArticleBioinformatics (Oxford, England)2026

PRISM-G: an interpretable privacy scoring framework for assessing risk in synthetic human genome data.

Alejandro Correa Rojo, Yves Moreau, Gökhan Ertaylan

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Alejandro Correa RojoESAT-STADIUS, KU Leuven, Leuven, 3001, Belgium.
Yves MoreauESAT-STADIUS, KU Leuven, Leuven, 3001, Belgium.
Gökhan ErtaylanEnvironmental Intelligence (EI), Flemish Institute for Technological Research (VITO), Mol, 2400, Belgium.

Funding

Beyond the Genome: Ethical Aspects of Large Cohort Studies Fonds voor Wetenschappelijk Onderzoek - Junior Project FN 701000004Research Council KU Leuven project SHARE: Synthetic Human genomes for Advanced Research and Ethical data sharing PDMT1/25/012
6 · The paper itself

Abstract

motivationSynthetic genomic data promises broader data access, but unresolved privacy risks remain a major concern. Existing evaluations often rely on similarity-based metrics that measure proximity between real and synthetic genomes, overlooking additional mechanisms through which genomic information may leak.

resultsWe introduce PRISM-G, a model-agnostic framework that quantifies privacy exposure in synthetic genomic data across three complementary components: proximity to real genomes in genetic-coordinate space, replay of familial or population-structure patterns, and trait-linked exposure through rare variants and membership-inference signals. These components are normalized and combined through a risk-averse aggregation into a single 0-100 PRISM-G score. By pairing PRISM-G with downstream utility metrics, the framework also enables analysis of privacy-utility trade-offs across generative models. We evaluated PRISM-G on synthetic cohorts generated by a generative adversarial network (GAN), a restricted Boltzmann machine (RBM), and a logic-based SAT solver (Genomator). Our results show that privacy vulnerabilities arise along different axes across models and marker densities, demonstrating that a single similarity-based metric is insufficient to characterize genomic privacy risk. AVAILABILITY AND IMPLEMENTATION: The source code of PRISM-G is available at https://github.com/alejocrojo09/prismg.

Indexed as

Genetic PrivacyGenome, HumanGenomicsSoftwareAlgorithmsGenerative Adversarial NetworksGenerative Artificial IntelligenceHumans

Identifiers

PMID42635217
PMCPMC13501313

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.